H 4607 Massachusetts House · 194th Legislature (2025-2026)

An Act relative to increasing access to epinephrine

This bill increases access to epinephrine for life-threatening allergic reactions by allowing pharmacists to dispense autoinjectors without a prescription under a statewide standing order, with liability protection for good-faith actions. It also shields first responders from drug possession charges when seeking medical help for anaphylaxis and permits businesses (like schools, restaurants, and sports venues) to maintain and store epinephrine supplies with staff training. Pharmacists must complete anaphylaxis recognition training, and all entities must report dispensing data anonymously to the state. The law aims to make emergency treatment more accessible while protecting those administering it.
Bill status in committee 1 of 4 stages cleared
Introduction
Oct 2025
Committee Review
Floor Vote
Governor
Introduced Oct 16, 2025 Last action May 20, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
10
Key actions
4
Committee
5
Amendments
1
May 20, 2026
Lower · Passed
Read second, amended (as recommended by the committee on House Ways and Means)
lower
May 20, 2026
Committee
Referred to the committee on House Steering, Policy and Scheduling with the amendment pending
lower
May 20, 2026
Lower · Passed
Committee recommended ought to pass with an amendment, substituting therefor a bill with the same title, see H5443
lower
Dec 4, 2025
Committee
Committee recommended bill ought to pass and referred to the committee on House Ways and Means
lower
Oct 16, 2025
Lower · Passed
Reported favorably by committee and referred to the committee on Health Care Financing
lower
Oct 16, 2025
Lower · Passed
Reported from the committee on Public Health
lower
0 primary · 23 co-sponsors

Sponsors

No sponsor information available.